Ottobock

Ottobock

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $15M

Overview

Ottobock is a century-old, privately-held leader in the orthotics and prosthetics (O&P) sector, with a strong global presence and a mission centered on human empowerment through mobility. The company leverages deep expertise in biomechanics, materials science, and microprocessor technology to create innovative, patient-specific solutions, from the flagship Genium and C-Leg prosthetic knees to the C-Brace orthosis and workplace exoskeletons. It operates a B2B2C model, supporting a global network of certified clinicians and technicians while engaging directly with end-users through community events, ambassador programs, and educational resources. Ottobock's financial stability is underpinned by its long-established commercial operations, diverse product lines, and recurring revenue from components and services.

Mobility ImpairmentLimb Loss/AmputationNeurological DisordersOrthopedic Rehabilitation

Technology Platform

Integrated platform combining advanced biomechanics, microprocessor control systems, sensor technology, myoelectric signal interpretation, and material science for prosthetic, orthotic, and exoskeleton solutions.

Funding History

1
Total raised:$15M
Grant$15M

Opportunities

Significant growth is driven by aging demographics, rising diabetes rates, and increasing focus on advanced rehabilitation and workplace ergonomics.
Expansion into emerging markets and the industrial exoskeleton segment presents substantial new revenue streams.
The integration of digital health tools for remote monitoring and data-driven care creates opportunities for deeper patient engagement and recurring service models.

Risk Factors

Key risks include global healthcare reimbursement pressures that may restrict access to premium-priced devices, intensifying competition from new tech-driven entrants, and supply chain vulnerabilities for critical electronic components.
Regulatory hurdles in key markets like the EU (MDR) and US (FDA) can also delay product launches and increase compliance costs.

Competitive Landscape

Ottobock competes with other large O&P companies like Össur (Iceland) and Fillauer (US), as well as specialized robotics firms like Ekso Bionics. In exoskeletons, competitors include Sarcos Robotics and Japanese firms like Cyberdyne. Its main competitive advantages are its century-old brand, unparalleled clinical network, deep biomechanical expertise, and full vertical integration from R&D to patient support.